A HCl/alcohol formulation increased 5-aminolevulinic acid skin distribution using an ex vivo full thickness porcine skin model

Experimental Dermatology

Volumn 17, Issue 10, 2008, Pages 813-820

  Maisch, Tim ^a   Worlicek, Christine ^a   Babilas, Philipp ^a   Landthaler, Michael ^a   Szeimies, Rolf Markus ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Distribution; Epidermis; Photodynamic; Porcine skin; Short chain alcohol

Indexed keywords

ALCOHOL; AMINOLEVULINIC ACID; DIMETHYL SULFOXIDE; KERASTICK; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREAM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; EPIDERMIS; EX VIVO STUDY; FEMALE; FLUORESCENCE MICROSCOPY; GEL; HYDROPHILICITY; ILLUMINATION; LIPOPHILICITY; NONHUMAN; OINTMENT; PHOTODYNAMICS; SKINFOLD THICKNESS; SWINE;

ALCOHOLS; AMINOLEVULINIC ACID; ANIMALS; FEMALE; HYDROCHLORIC ACID; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN; SURGICAL TAPE; SUS SCROFA;

EID: 51949095052     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00705.x     Document Type: Article

References (42)

1. Aveline B. Primary processes in photosensitization mechanisms. Compr Ser Photosci 2001: 2: 17-34.
2. Dougherty T J, Grindey G B, Fiel R, Weishaupt K R, Boyle D G. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 1975: 55: 115-121.
3. Dougherty T J, Gomer C J, Henderson B W et al. Photodynamic therapy. J Natl Cancer Inst 1998: 90: 889-905.
4. Akilov O E, Kosaka S, O'Riordan K, Hasan T. Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells. Exp Dermatol 2007: 16: 651-660.
5. Braathen L R, Szeimies R M, Basset-Seguin N et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007: 56: 125-143.
6. Calzavara-Pinton P G, Venturini M, Sala R. Photodynamic therapy: Update 2006. Part 1. Photochemistry and photobiology. J Eur Acad Dermatol Venereol 2007: 21: 293-302.
7. Babilas P, Landthaler M, Szeimies R M. Photodynamic therapy in dermatology. Eur J Dermatol 2006: 16: 340-348.
8. Barker D E. Skin thickness in the human. Plast Reconstr Surg 1951: 7: 115-116.
9. Lee Y, Hwang K. Skin thickness of Korean adults. Surg Radiol Anat 2002: 24: 183-189.
10. Hwang K, Kim D J, Lee I J. An anatomic comparison of the skin of five donor sites for dermal fat graft. Ann Plast Surg 2001: 46: 327-331.
11. Meyer W, Schwarz R, Neurand K. The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig. Curr Probl Dermatol 1978: 7: 39-52.
12. Simon G A, Maibach H I. The pig as an experimental animal model of percutaneous permeation in man: Qualitative and quantitative observations - an overview. Skin Pharmacol Appl Skin Physiol 2000: 13: 229-234.
13. Jacobi U, Meykadeh N, Sterry W, Lademann J. Effect of the vehicle on the amount of stratum corneum removed by tape stripping. J Dtsch Dermatol Ges 2003: 1: 884-889.
14. Cross S E, Magnusson B M, Winckle G, Anissimov Y, Roberts M S. Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J Invest Dermatol 2003: 120: 759-764.
15. Kanikkannan N, Kandimalla K, Lamba S S, Singh M. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 2000: 7: 593-608.
16. Schaefer H, Stuttgen G, Zesch A, Schalla W, Gazith J. Quantitative determination of percutaneous absorption of radiolabeled drugs in vitro and in vivo by human skin. Curr Probl Dermatol 1978: 7: 80-94.
17. Jacobi U, Tassopoulos T, Surber C, Lademann J. Cutaneous distribution and localization of dyes affected by vehicles all with different lipophilicity. Arch Dermatol Res 2006: 297: 303-310.
18. Kandimalla K K, Kanikkannan N, Singh M. Optimization of a vehicle mixture for the transdermal delivery of melatonin using artificial neural networks and response surface method. J Control Release 1999: 61: 71-82.
19. Maisch T, Bosl C, Szeimies R M, Love B, Abels C. Determination of the antibacterial efficacy of a new porphyrin-based photosensitizer against MRSA ex vivo. Photochem Photobiol Sci 2007: 6: 545-551.
20. Schacht V, Becker K, Szeimies R M, Abels C. Apoptosis and leucocyte-endothelium interactions contribute to the delayed effects of cryotherapy on tumours in vivo. Arch Dermatol Res 2002: 294: 341-348.
21. Peng Q, Warloe T, Berg K et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997: 79: 2282-2308.
22. Moan J, Peng Q, Evensen J F, Berg K, Western A, Rimington C. Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol 1987: 46: 713-721.
23. van den Akker J T, Boot K, Vernon D I et al. Effect of elevating the skin temperature during topical ALA application on in vitro ALA penetration through mouse skin and in vivo PpIX production in human skin. Photochem Photobiol Sci 2004: 3: 263-267.
24. Williams A C, Barry B W. Penetration enhancers. Adv Drug Deliv Rev 2004: 56: 603-618.
25. Goates C Y, Knutson K. Enhanced permeation of polar compounds through human epidermis. I. Permeability and membrane structural changes in the presence of short chain alcohols. Biochim Biophys Acta 1994: 1195: 169-179.
26. Kurihara-Bergstrom T, Knutson K, DeNoble L J, Goates C Y. Percutaneous absorption enhancement of an ionic molecule by ethanol-water systems in human skin. Pharm Res 1990: 7: 762-766.
27. Elias P M, Tsai J, Menon G K, Holleran W M, Feingold K R. The potential of metabolic interventions to enhance transdermal drug delivery. J Investig Dermatol Symp Proc 2002: 7: 79-85.
28. Tsai J C, Hung P L, Sheu H M. Molecular weight dependence of polyethylene glycol penetration across acetone-disrupted permeability barrier. Arch Dermatol Res 2001: 293: 302-307.
29. Al-Bawab A. Investigation of the phase behavior and an evaporation study of systems of lavender oil, water, Laureth 4, and Tween 80. J Cosmet Sci 2003: 54: 429-441.
30. Winkler A, Muller-Goymann C C. The influence of topical formulations on the permeation of 5-aminolevulinic acid and its n-butyl ester through excised human stratum corneum. Eur J Pharm Biopharm 2005: 60: 427-437.
31. Priborsky J, Takayama K, Nagai T, Waitzova D, Elis J. Combination effect of penetration enhancers and propylene glycol on in vitro transdermal absorption of insulin. Drug Des Deliv 1987: 2: 91-97.
32. Donnelly R F, McCarron P A, Woolfson A D. Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy. Photochem Photobiol 2005: 81: 750-767.
33. De Rosa F S, Marchetti J M, Thomazini J A, Tedesco A C, Bentley M V. A vehicle for photodynamic therapy of skin cancer: Influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J Control Release 2000: 65: 359-366.
34. Casas A, Fukuda H, Di Venosa G, Batlle A. Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy. Br J Cancer 2001: 85: 279-284.
35. Anigbogu A N, Williams A C, Barry B W, Edwards H G M. Fourier transform Raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum. Int J Pharm 1995: 125: 265-282.
36. Al-Saidan S M, Selkirk A B, Winfield A J. Effect of dimethylsulfoxide concentration on the permeability of neonatal rat stratum corneum to alkanols. J Invest Dermatol 1987: 89: 426-429.
37. Kligman A M. Topical pharmacology and toxicology of dimethyl sulfoxide. 1. JAMA 1965: 193: 796-804.
38. Auner B G, Petzenhauser E, Valenta C. Influence of 6-ketocholestanol on skin permeation of 5-aminolevulinic acid and evaluation of chemical stability. J Pharm Sci 2004: 93: 2780-2787.
39. Juzeniene A, Juzenas P, Iani V, Moan J. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: Considerations for dosimetry in mouse skin model. Photochem Photobiol 2002: 76: 329-334.
40. Juzeniene A, Juzenas P, Ma L W, Iani V, Moan J. Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin. Br J Dermatol 2006: 155: 791-799.
41. Panchagnula R, Stemmer K, Ritschel W A. Animal models for transdermal drug delivery. Methods Find Exp Clin Pharmacol 1997: 19: 335-341.
42. Benech-Kieffer F, Wegrich P, Schwarzenbach R et al. Percutaneous absorption of sunscreens in vitro: Interspecies comparison, skin models and reproducibility aspects. Skin Pharmacol Appl Skin Physiol 2000: 13: 324-335.